{
    "2020-12-01": [
        [
            {
                "time": "2020-12-01",
                "original_text": "恒瑞医药他达拉非片获批上市，视同通过仿制药一致性评价。",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "他达拉非片",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "北向资金净买入162.93亿元，连续4日净买入。",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "连续4日"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "疫情叠加集采致业绩大降，中国生物制药暴跌11%，盈利能力下降。",
                "features": {
                    "keywords": [
                        "疫情",
                        "集采",
                        "中国生物制药",
                        "暴跌",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "医保集采下的药品销售：灰色链条是否还在？",
                "features": {
                    "keywords": [
                        "医保集采",
                        "药品销售",
                        "灰色链条"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-01",
                "original_text": "短期看复苏，长期看赛道：医药生物行业2021年上半年投资策略。",
                "features": {
                    "keywords": [
                        "短期复苏",
                        "长期赛道",
                        "医药生物",
                        "投资策略"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}